(Q47391807)

15 January 2018

title

Octreotide treatment does not affect the size of most non-functioning pituitary adenomas (English)

1 reference

15 January 2018

author name string

M Gasperi

1

1 reference

15 January 2018

L Petrini

2

1 reference

15 January 2018

R Pilosu

3

1 reference

15 January 2018

M Nardi

4

1 reference

15 January 2018

A Marcello

5

1 reference

15 January 2018

F Mastio

6

1 reference

15 January 2018

L Bartalena

7

1 reference

15 January 2018

E Martino

8

1 reference

15 January 2018

publication date

1 July 1993

1 reference

15 January 2018

Journal of Endocrinological Investigation

published in

1 reference

15 January 2018

volume

16

1 reference

15 January 2018

issue

7

1 reference

15 January 2018

page(s)

541-543

1 reference

15 January 2018

https://scigraph.springernature.com/pub.10.1007/bf03348901

exact match

0 references

cites work

The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors

1 reference

https://api.crossref.org/works/10.1007%2FBF03348901

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348901

Specific somatostatin receptors on human pituitary adenoma cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348901

The role of octreotide (Sandostatin) in non-growth hormone-, non-thyroid-stimulating hormone-, and non-prolactin-secreting adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348901

In VivoDetection of Somatostatin Receptors in Patients with Functionless Pituitary Adenomas by Means of a Radioiodinated Analog of Somatostatin ([123I]SDZ 204–090)*

21 January 2018

1 reference

12 December 2020

Somatostatin-receptor imaging in the localization of endocrine tumors

1 reference

12 December 2020

Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions

1 reference

12 December 2020

Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995

1 reference

12 December 2020

Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses

1 reference

12 December 2020

Octreotide steaming ahead

1 reference

12 December 2020

Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group

1 reference

12 December 2020

Thyrotropin-Secreting Pituitary Adenomas: Report of Seven Cases

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03348901

1 reference

15 January 2018

1 reference

15 January 2018